相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting
Rudolph M. Navari
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity
Sierra Vig et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Study
Naomi Mizukami et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2014)
Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review
Christopher M. Hocking et al.
SUPPORTIVE CARE IN CANCER (2014)
A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting
Xiao-fei Wang et al.
SCIENTIFIC REPORTS (2014)
Management of Chemotherapy-Induced Nausea and Vomiting Focus on Newer Agents and New Uses for Older Agents
Rudolph M. Navari
DRUGS (2013)
The current status of the use of palonosetron
Rudolph Navari
EXPERT OPINION ON PHARMACOTHERAPY (2013)
The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
Rudolph M. Navari et al.
SUPPORTIVE CARE IN CANCER (2013)
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Antiemetics for Chemotherapy-Induced Nausea and Vomiting Occurring Despite Prophylactic Antiemetic Therapy
Jason M. Jones et al.
JOURNAL OF PALLIATIVE MEDICINE (2011)
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
F. Roila et al.
ANNALS OF ONCOLOGY (2010)
Reduced Ghrelin Secretion in the Hypothalamus of Rats due to Cisplatin-Induced Anorexia
Koji Yakabi et al.
ENDOCRINOLOGY (2010)
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer
Rudolph M. Navari
FUTURE ONCOLOGY (2010)
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study
Bernardo L. Rapoport et al.
SUPPORTIVE CARE IN CANCER (2010)
Aprepitant A Review of its Use in the Prevention of Nausea and Vomiting
Monique P. Curran et al.
DRUGS (2009)
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Lijun Tan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study
Rudolph M. Navari et al.
SUPPORTIVE CARE IN CANCER (2007)
Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy
Ya-Chen Tina Shih et al.
CANCER (2007)
Chemotherapy-induced nausea and vomiting-incidence and impact on patient quality of life at community oncology settings
Lorenzo Cohen et al.
SUPPORTIVE CARE IN CANCER (2007)
Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment
Brigitte Bloechl-Daum et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin
JA Rudd et al.
NEUROSCIENCE LETTERS (2006)
A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group study
RM Navari et al.
SUPPORTIVE CARE IN CANCER (2005)
Incidence of chemotherapy-induced nausea and emesis after modern antiemetics - Perception versus reality
SM Grunberg et al.
CANCER (2004)
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - The Aprepitant Protocol 052 Study Group
PJ Hesketh et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics - A University of Rochester James P. Wilmot Cancer Center community clinical oncology program study of 360 cancer patients treated in the community
JT Hickok et al.
CANCER (2003)
A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain
SD Passik et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine
FP Bymaster et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
分享论文
